Gilead's Immunomedics settles over-hyped ASCO data mishap for $4M - Endpoints News

Each year, the American Society of Clinical Oncology's prestigious annual meeting unveils some of the latest and greatest new cancer data, occasionally making or breaking smaller biotechs along the way. In 2016, this was the case for a clinical-stage biotech …

Each year, the Amer­i­can So­ci­ety of Clin­i­cal On­col­o­gy’s pres­ti­gious an­nu­al meet­ing un­veils some of the lat­est and great­est new can­cer da­ta, oc­ca­sion­al­ly mak­ing or break­ing sma… [+2292 chars]

full article...